nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A gene signature of cancer-associated fibroblasts predicts prognosis and treatment response in bladder cancer
|
Chen, Xi |
|
|
26 |
2 |
p. 477-495 |
artikel |
2 |
A nomogram based on 4-lncRNAs signature for improving prognostic prediction of hepatocellular carcinoma
|
Mo, Qingguo |
|
|
26 |
2 |
p. 375-388 |
artikel |
3 |
Bone metastatic cancer of unknown primary at initial presentation
|
Matsuoka, Masatake |
|
|
26 |
2 |
p. 461-467 |
artikel |
4 |
Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era
|
Xie, Xiaohong |
|
|
26 |
2 |
p. 434-445 |
artikel |
5 |
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)
|
Ayala de la Peña, Francisco |
|
|
26 |
2 |
p. 555-556 |
artikel |
6 |
Correction to: Efficacy and safety of trifluridine/tipiracil (TAS‑102) in patients with metastatic colorectal cancer: a systematic review and meta‑analysis
|
Huang, Fengxiang |
|
|
26 |
2 |
p. 554 |
artikel |
7 |
Correction to: Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors
|
Liu, Chang |
|
|
26 |
2 |
p. 557 |
artikel |
8 |
Correction to: The mechanism of VCP‑mediated metastasis of osteosarcoma based on cell autophagy and the EMT pathway
|
Li, An An |
|
|
26 |
2 |
p. 558-560 |
artikel |
9 |
Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitors
|
Pinto, Álvaro |
|
|
26 |
2 |
p. 532-537 |
artikel |
10 |
Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis
|
Huang, Fengxiang |
|
|
26 |
2 |
p. 468-476 |
artikel |
11 |
Energy metabolism: a new target for gastric cancer treatment
|
Liu, Jiangrong |
|
|
26 |
2 |
p. 338-351 |
artikel |
12 |
Glioblastoma research on zebrafish xenograft models: a systematic review
|
Pliakopanou, Alexandra |
|
|
26 |
2 |
p. 311-325 |
artikel |
13 |
Is surgical indication in multiple myeloma a poor prognosis sign? SEER database analysis
|
Öztürk, Recep |
|
|
26 |
2 |
p. 524-531 |
artikel |
14 |
LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma
|
Zhang, Ling |
|
|
26 |
2 |
p. 414-423 |
artikel |
15 |
Mechanism of action and treatment of type I interferon in hepatocellular carcinoma
|
Peng, Chunxiu |
|
|
26 |
2 |
p. 326-337 |
artikel |
16 |
MicroRNA-128 acts as a suppressor in the progression of gastrointestinal stromal tumor by targeting B-lymphoma Mo-MLV insertion region 1
|
Wu, Jinbao |
|
|
26 |
2 |
p. 363-374 |
artikel |
17 |
Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience
|
Serrano, Marina |
|
|
26 |
2 |
p. 549-553 |
artikel |
18 |
Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival
|
Tang, Yaxiong |
|
|
26 |
2 |
p. 446-455 |
artikel |
19 |
Prognostic model of ER-positive, HER2-negative breast cancer predicted by clinically relevant indicators
|
Song, Xinming |
|
|
26 |
2 |
p. 389-397 |
artikel |
20 |
Prognostic value of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: a meta-analysis
|
Yan, Chengkun |
|
|
26 |
2 |
p. 515-523 |
artikel |
21 |
Proteomics-based clustering of lung adenocarcinoma identifies three subtypes with significantly different clinical and molecular features
|
Long, Rongzhuo |
|
|
26 |
2 |
p. 538-548 |
artikel |
22 |
Status of head and neck brachytherapy in Spain in 2022
|
Guinot, Jose Luis |
|
|
26 |
2 |
p. 456-460 |
artikel |
23 |
Surface guided radiation therapy with an innovative open-face mask and mouth bite: patient motion management in brain stereotactic radiotherapy
|
Chen, Xuemei |
|
|
26 |
2 |
p. 424-433 |
artikel |
24 |
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium
|
Viñolas, Nuria |
|
|
26 |
2 |
p. 352-362 |
artikel |
25 |
The role of the mitochondrial ribosomal protein family in detecting hepatocellular carcinoma and predicting prognosis, immune features, and drug sensitivity
|
Zhao, Jin-Wei |
|
|
26 |
2 |
p. 496-514 |
artikel |
26 |
Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation
|
Miao, Yajun |
|
|
26 |
2 |
p. 398-413 |
artikel |